Skip to main content

An open-label, long-term study of risperidone for the treatment of behavioral disturbances in patients with dementia

An open-label, long-term study of risperidone for the treatment of behavioral disturbances in patients with dementia


NCT Number

Not Available


Primary Citation

Trial has yet to be published


Data Specification

Not Available


Annotated CRF

Not Available

Data Request Dashboard

Operations

No data requests found. Click here to generate a new one.

Product Info

Generic Name
Risperidone
Product Name
RISPERDAL®
Therapeutic Area
Behaviors and Mental Disorders
Enrollment
330
% Female
N/A
% White
N/A
Product Class
Atypical Antipsychotics
Sponsor Protocol Number
RIS-USA-70 (EXTENSION OF RIS-USA-63) CR003361, RIS-USA-T216
Data Holder
Johnson & Johnson
Condition Studied
Dementia
Mean/Median Age (Years)
N/A

Supporting Documentation

Data Definition Specification Available
Annotated Case Report Form Available
Clinical Study Report
Collected Datasets
Study Phase 
3

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.